Lycia Therapeutics, Inc. went public at $18.00 a share
It sold 17,640,000 shares on Nasdaq Global Select Market under the ticker LYCA and raised $317.5 million before costs.
Final prospectus (424B4) filed October 23, 2026
The terms
-
Offered
17,640,000 shares
Checked
Source
“We are offering 17,640,000 shares of our common stock.”
A model read this, and code confirmed the quote appears in the filing. -
Price per share
$18.00
Checked
Source
“The initial public offering price is $18.00 per share.”
A model read this, and code confirmed the quote appears in the filing. -
Raised
$317,520,000before fees and costs
Checked
Source and check
Shares × price = 17,640,000 × $18.00 = $317,520,000. They match.
“Initial Public Offering Price | $18.00 | $317,520,000”
A model read this, and code confirmed the quote appears in the filing. -
Bank fee
$22,226,400$1.26 a share, 7.0% of the raise
Checked
Source
“Underwriting Discounts and Commissions(1) | $1.26 | $22,226,400”
A model read this, and code confirmed the quote appears in the filing. -
Company receives first
$295,293,600before other costs
Checked
Source and check
Raised − bank fee = $317,520,000 − $22,226,400 = $295,293,600. They match.
“Proceeds to Lycia Therapeutics, Inc., Before Expenses | $16.74 | $295,293,600”
A model read this, and code confirmed the quote appears in the filing. -
Lead banks
Jefferies, TD Cowen, Evercore ISI, Guggenheim Securities
From the prospectus
Source
“Jefferies | TD Cowen | Evercore ISI | Guggenheim Securities”
A model read this, and code confirmed the quote appears in the filing. -
Trades as
LYCA on Nasdaq Global Select Market
Checked
Source
“Our common stock has been approved for listing on the Nasdaq Global Select Market under the symbol “LYCA.””
A model read this, and code confirmed the quote appears in the filing. -
Extra for the banks
Up to 2,646,000 sharesan option the banks may use
From the prospectus
Source
“We have granted the underwriters an option for a period of 30 days to purchase up to an additional 2,646,000 shares of our common stock.”
A model read this, and code confirmed the quote appears in the filing. - Final prospectus filed October 23, 2026
Not investment advice.Open the filing on SEC.gov
Where the money goes first
The banks take their fee before the company sees the money.
Who owns the company after the IPO
From the prospectus 17,640,000 of 55,034,559 shares outstanding after the offering (32.1%).
Where Lycia Therapeutics, Inc. sits among the last 12 months
Each bubble is one IPO. Bigger and higher means more money raised. The scale grows by ten times at each line.
New to these terms? How to read an IPO.